胃癌原发灶与区域淋巴结转移的空间图谱揭示肿瘤播散原则
研究对64例胃癌切除样本的原发灶浅层、深层及配对淋巴结转移区域进行转录组、NGS、MLPA和形态学分析,发现淋巴结转移更可能起源于原发灶深层亚区,且治疗相关基因的改变仅在深层或转移灶中检出。
要点
- 胃癌淋巴结转移可能起源于原发灶深层亚区而非浅层。
- 深层和转移灶中治疗相关基因改变可能被浅层活检漏检。
- 靶向治疗试验需评估原发灶深层和/或转移灶。
核心结论
- 胃癌区域淋巴结转移可能起源于原发肿瘤的深层亚区。
- 未来靶向治疗临床试验需评估原发灶深层和/或转移灶,因多个治疗相关基因仅在这些区域突变、过表达或扩增。
研究设计与样本
- 对胃癌切除样本标注原发肿瘤浅层、原发肿瘤深层和淋巴结转移亚区。
- 每个亚区进行转录组分析(NanoString PanCancer Progression Panel,770基因)、NGS(225个胃肠道肿瘤相关基因)、MLPA(16基因)和組織形态学表型分析。
主要发现
- 64例胃癌的NanoString分析显示原发浅层1与浅层2间无差异。
- 原发浅层与深层间43%基因差异表达,原发浅层与淋巴结转移间38%基因差异表达。
- 原发深层与淋巴结转移间仅16%基因差异表达。
- IGF1、PIK3CD和TGFB1等具治疗潜力基因在淋巴结转移和原发深层中较原发浅层过表达。
- NGS显示40%突变存在于原发深层和/或淋巴结转移但不在原发浅层,仅6%突变存在于原发浅层而原发深层和淋巴结转移中缺失。
关键数值与推荐
- MLPA显示亚区之间显著的空间异质性及从原发浅层到原发深层/淋巴结转移的渐进性基因组改变。
临床怎么用
- 解读胃原发灶浅层活检结果时需考虑空间异质性可能导致的信息偏差。
- 靶向治疗决策和临床试验设计应纳入原发灶深层和/或转移灶的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endoscopic mucosal biopsies of primary gastric cancers (GCs) are used to guide diagnosis, biomarker testing and treatment. Spatial intratumoural heterogeneity (ITH) may influence biopsy-derived information. We aimed to study ITH of primary GCs and matched lymph node metastasis (LNmet). DESIGN: GC resection samples were annotated to identify primary tumour superficial (PTsup), primary tumour deep (PTdeep) and LNmet subregions. For each subregion, we determined (1) transcriptomic profiles (NanoString 'PanCancer Progression Panel', 770 genes); (2) next-generation sequencing (NGS, 225 gastrointestinal cancer-related genes); (3) DNA copy number profiles by multiplex ligation-dependent probe amplification (MLPA, 16 genes); and (4) histomorphological phenotypes. RESULTS: NanoString profiling of 64 GCs revealed no differences between PTsup1 and PTsup2, while 43% of genes were differentially expressed between PTsup versus PTdeep and 38% in PTsup versus LNmet. Only 16% of genes were differently expressed between PTdeep and LNmet. Several genes with therapeutic potential (eg IGF1, PIK3CD and TGFB1) were overexpressed in LNmet and PTdeep compared with PTsup. NGS data revealed orthogonal support of NanoString results with 40% mutations present in PTdeep and/or LNmet, but not in PTsup. Conversely, only 6% of mutations were present in PTsup and were absent in PTdeep and LNmet. MLPA demonstrated significant ITH between subregions and progressive genomic changes from PTsup to PTdeep/LNmet. CONCLUSION: In GC, regional lymph node metastases are likely to originate from deeper subregions of the primary tumour. Future clinical trials of novel targeted therapies must consider assessment of deeper subregions of the primary tumour and/or metastases as several therapeutically relevant genes are only mutated, overexpressed or amplified in these regions.
引用
- Sundar R, Liu DH, Hutchins GG, et al. Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. Gut. 2020. PMID: 33229445. doi:10.1136/gutjnl-2020-320805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。